AlphaYouSH
Insider selling
Stephen Hoge sold $2.6M of Moderna, Inc. (MRNA) stock
Stephen Hoge, President of Moderna, Inc. (MRNA), sold 53,336 shares of MRNA stock worth $2.6M, per an SEC Form 4 filed May 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 15, 2026, 3 days before it was made public.
MRNA has moved +252.7% since the trade date, from $49.04 to $172.94 (Sep 21, 2026 close).
- Traded
- May 15, 2026
- Disclosed
- May 18, 2026
- Filing delay
- 3 days
- Price since
- +252.7%
- Role
- President
- Source
- SEC Form 4
More MRNA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.